Chan, I. S., Philips, G. M., Zdanowicz, M., Teaberry, V., Karaca, G., Rangwala, F., … Diehl, A. M. (2011). HEDGEHOG PATHWAY INHIBITION BY GDC-0449 CAUSES REGRESSION OF HEPATOCELLULAR CARCINOMAS AND IMPROVES LIVER FIBROSIS IN MDR2-DEFICIENT MICE. In HEPATOLOGY (Vol. 54, pp. 1278A-1278A). San Francisco, CA: WILEY-BLACKWELL.

Chan, Isaac S., George M. Philips, Marzena Zdanowicz, Vanessa Teaberry, Gamze Karaca, Fatima Rangwala, Cynthia D. Guy, et al. “HEDGEHOG PATHWAY INHIBITION BY GDC-0449 CAUSES REGRESSION OF HEPATOCELLULAR CARCINOMAS AND IMPROVES LIVER FIBROSIS IN MDR2-DEFICIENT MICE.” In HEPATOLOGY, 54:1278A-1278A. WILEY-BLACKWELL, 2011.

Chan IS, Philips GM, Zdanowicz M, Teaberry V, Karaca G, Rangwala F, et al. HEDGEHOG PATHWAY INHIBITION BY GDC-0449 CAUSES REGRESSION OF HEPATOCELLULAR CARCINOMAS AND IMPROVES LIVER FIBROSIS IN MDR2-DEFICIENT MICE. In: HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 1278A-1278A.

Chan, Isaac S., et al. “HEDGEHOG PATHWAY INHIBITION BY GDC-0449 CAUSES REGRESSION OF HEPATOCELLULAR CARCINOMAS AND IMPROVES LIVER FIBROSIS IN MDR2-DEFICIENT MICE.” HEPATOLOGY, vol. 54, WILEY-BLACKWELL, 2011, pp. 1278A-1278A.

Chan IS, Philips GM, Zdanowicz M, Teaberry V, Karaca G, Rangwala F, Guy CD, Moylan CA, Venkatraman T, Feuerlein S, Syn W-K, Jung Y, Witek RP, Michelotti GA, Choi SS, Merkle EM, Lascola C, Diehl AM. HEDGEHOG PATHWAY INHIBITION BY GDC-0449 CAUSES REGRESSION OF HEPATOCELLULAR CARCINOMAS AND IMPROVES LIVER FIBROSIS IN MDR2-DEFICIENT MICE. HEPATOLOGY. WILEY-BLACKWELL; 2011. p. 1278A-1278A.